McQuilling John P, Sanders Mitchell, Poland Lindsay, Sanders Mia, Basadonna Giacomo, Waldrop Norman E, Mowry Katie C
Organogenesis Inc, Research and Development, Birmingham, AL.
Alira Health, Framingham, MA.
Wounds. 2019 Jan;31(1):19-25. Epub 2018 Oct 26.
Healing of tendon injuries is often plagued by significant scar formation and compromised biomechanical function. For those with diabetes, these injuries are further complicated by alterations to the extracellular matrix of the tendon, poor circulation, and delayed wound healing; consequently, complications and re-rupture rates for patients with diabetes are reported higher than the typical patient population. Placental derived membranes, specifically dehydrated human amnion/chorion membranes (dACMs), have been utilized clinically as an adhesion barrier, and these membranes have been shown to reduce scarring and aid in tissue repair.
The purpose of this study was to evaluate the effect of dACMs on tendon repair in a diabetic model with impaired healing.
Using a type II diabetic model (BBZDR/WOR rats), a full-thickness injury was made through the Achilles tendon and repaired using a modified Kessler method. Repaired tendons were wrapped with dACM or left unwrapped as a control (n = 15/group; n = 30 total). Tendons were retrieved at 14 (n = 5/group; n = 10 total) or 28 days (n = 10/group; n = 20 total) and evaluated using histology, immunofluorescence, and biomechanical testing.
Treatment of tendons with dACM resulted in reduced failure rates, increased cell migration, and improved mechanical properties (compared with unwrapped controls). The dACM-treated tendons also showed changes in the production of several important biomarkers to tendon healing at both 14 and 28 days; most notably, Scleraxis was found to be upregulated in dACM-treated tendons.
This study highlights a promising treatment option for this challenging clinical population.
肌腱损伤的愈合常常受到大量瘢痕形成和生物力学功能受损的困扰。对于糖尿病患者,这些损伤因肌腱细胞外基质的改变、血液循环不良和伤口愈合延迟而进一步复杂化;因此,据报道糖尿病患者的并发症和再破裂率高于普通患者群体。胎盘来源的膜,特别是脱水人羊膜/绒毛膜(dACM),已在临床上用作粘连屏障,并且这些膜已被证明可减少瘢痕形成并有助于组织修复。
本研究的目的是评估dACM对愈合受损的糖尿病模型中肌腱修复的影响。
使用II型糖尿病模型(BBZDR/WOR大鼠),通过跟腱制造全层损伤,并使用改良的凯斯勒方法进行修复。修复后的肌腱用dACM包裹或不包裹作为对照(每组n = 15;共n = 30)。在14天(每组n = 5;共n = 10)或28天(每组n = 10;共n = 20)取出肌腱,并使用组织学、免疫荧光和生物力学测试进行评估。
用dACM治疗肌腱可降低失败率、增加细胞迁移并改善力学性能(与未包裹的对照相比)。在14天和28天时,dACM处理的肌腱在几种对肌腱愈合重要的生物标志物的产生方面也表现出变化;最显著的是,在dACM处理的肌腱中发现Scleraxis上调。
本研究突出了针对这一具有挑战性的临床群体的一种有前景的治疗选择。